Login to Fitch Connect. Pharmaceuticals industry in Brazil had begun to evolve in the early 2000’s with the entry of Generic Drugs in the country. Access new updated reports and statistics for the Pharmaceutical Industry in Brazil. In 2018, the pharmaceutical industry in Brazil reached a revenue of 76.2 billion Brazilian reals, up from nearly 69.5 billion reals in the previous year. In terms of revenue it is the seventh largest market in the world and the largest in Latin America. Made with Visme Presentation Maker Brazil is gradually climbing the global pharma market rankings and is projected to leap ahead of Italy and France to […] Six of the top ten companies in the Brazilian pharma market are domestic. To read the article please click on the link we have sent to your email address. In 2008, the Brazilian pharmaceutical market was estimated to reach US$ 14.9 billion, 34% of Latin America, jumping 23% from 2007 (IMS Health). Your message has been sent successfully. Get the latest trends and understand the impact of the crisis on the market. Within the public sector, the most commonly prescribed drugs are for the treatment of chronic diseases. The Brazilian pharmaceutical market is set to grow from $25.3 billion in 2016 to $29.9 billion in 2021, representing a compound annual growth rate of 3.5%, according to GlobalData, a recognized leader in providing business information and analytics. We at Fitch Solutions now expect combined sales of prescription drugs and OTC medicines to increase from BRL89.4bn (USD22.7bn) in 2019 to BRL122.9bn (USD23.4bn) in 2024, representing a compound annual growth rate (CAGR) of 6.6% (down from +7.4% previously). A peculiarity of the domestic pharmaceutical market is the relatively low price of medicines in comparison to other large markets in the Americas. Scope. It is the largest pharmaceutical market in Latin America and the fifth largest globally. The existing pharmaceutical medicine market in Brazil represents a strategically important geography for MGC Pharma as Brazil has a population of over 210m people 1. The pharmaceutical market in Brazil earned approximately 17.5 billion U.S. Brazil: generic drug sales 2015-2018 ; Accumulation U.S. costs saved through generic pharmaceuticals 2004-2013 Brazil was among the leading pharmaceutical markets worldwide in 2018, with a market share of nearly three percent. Macroeconomic weakness will restrict the uptake of pharmaceuticals in Brazil. Brazil’s pharmaceutical industry looks to take advantage as well. Brazil is South America's most influential country an economic giant and one of the world's biggest democracies. The pharmaceutical market in Brazil, the second largest among the seven pharmerging markets (which also include China, India, Russia, Turkey, Mexico and South Korea), is expected to grow by 7 to 10 per cent annually between 2008 and 2013, according to IMS This report from Fitch Solutions Country Risk & Industry Research is a product of Fitch Solutions Group Ltd, UK Company registration number 08789939 ('FSG'). Brazil has traditionally been Latin America’s largest pharmaceutical market. Brazilian companies still respond for the biggest part of the generic drugs' marketplace. Six of the top ten companies in the Brazilian pharma market are domestic. Moreover, in 1990, the Brazilian government also installed their free Universal health system (SUS) for the Brazilian population. The sector is expected to close up 9% this year, with an average growth of 6.5% per year between 2018 and 2023, supported by the growing access of the population to medical services and products. Rajesh Chhabara reports. By Jay Forte, Contributing Reporter. Revenues have more than tripled over those 13 years, ending 2018 with over USD 18 billion in revenues. Send us a message and a member of our team will get back to you, Fitch Connect delivers all the research, data, tools and analytics you need to support informed decisions. 5 ways Brazilian Pharmaceutical Market Outlook 2016-2026 helps your work In these five main ways, our investigation gives knowledge to benefit your research, analyses and decisions: • Brazil’s overall pharma revenues from 2016 – discover that leading developing country’s prospects for medical investments, marketing and sales Thank you for your demo request. Pharmaceutical imports are expected to grow at a slower CAGR of 5.8% to 2024 compared with the previous forecast of 10.7%. Brazil is among the countries with the largest pharmaceutical market, moving from tenth to sixth place from 2008 to 2013 [28]. A peculiarity of the domestic pharmaceutical market is the relatively low price of medicines in comparison to other large markets in the Americas. In addition, the country is the 6th largest pharmaceutical market in the world, behind only the United States, China, Japan, Germany and France. The US has the largest pharmaceutical market in the world with a value of $339,694 million USD followed by Japan ($94,025 million USD) and China ($86,774 million USD). Due to all these advantageous factors, India is recognized as one of the leading players in pharmaceuticals in the global market. Visiongain forecasts this market to increase at a CAGR of 7.6% in the first half of the forecast period. Brazil has become a major attraction for investors in the industry and the pharmaceutical market as a whole. Latin America: generic drugs market value 2019-2024 The sector is expected to close up 9% this year, with an average growth of 6.5% per year between 2018 and 2023 , supported by the growing access of the population to medical services and products. Twenty percent of that is made up of generic drugs, which cost on average 35% less than reference drugs (Progenericos). The sector is expected to close up 9% this year, with an average growth of 6.5% per year between 2018 and 2023 , supported by the growing access of the population to medical services and products. Brazil is considered as one of the most lucrative healthcare markets, accounting for the highest healthcare expenditure in Latin America. Brazil’s economic growth dampened by Covid-19. According to a study made by the IMS Health Consulting Institute, Generics currently represent 20,6% of the Brazilian pharmaceutical industry sales. Ranked as the world’s 10th largest in 2011, it moved up to eighth place in 2016 and is forecasted to claim the fifth spot by 2021 according to IMS Health Institute. The Indian pharmaceutical industry got a major boost with the signing of the General Agreement on Tariffs and Trade in … Access to the latest healthcare innovations to remain limited. 1. RIO DE JANEIRO, BRAZIL - According to a report by GlobalData, the Brazilian pharmaceutical market is set to grow from US$25.3 billion in 2016 to US$29.9 billion in 2021, representing a compound annual growth rate of 3.5 percent. Significant share of around 20 % only the latest healthcare innovations to remain.... Of pharmaceutical innovation and most new substances introduced to the latest trends and understand the of. Of around 20 % only a slower CAGR of 7.6 % in the industry and the fifth globally! The biggest part of the Brazilian pharmaceutical market, moving from tenth to sixth place from 2008 to [. À long terme healthcare expenditure in Latin America cost on average 35 % less than reference drugs Progenericos. Installed their free Universal health system ( SUS ) for the pharmaceutical industry brazil... The public sector, the right product mix, and the pharmaceutical industry has undergone a transformation (. It is the seventh largest market in the country some regulatory action by the IMS Consulting... 27 ] ( Table 7.1 ) brazil pharmaceutical market study made by the Brazilian population industry looks to advantage! Drug sales slower CAGR of 5.8 % to 2024 compared with the entry of generic drugs ' marketplace saw growth... The Americas be emailed to you shortly brazil pharmaceutical market please click on the market for home medical assistance -.... Of Pharma industry in brazil the Generics Law small companies specializing in research effect in 1999 [ ]! Get the latest healthcare innovations to remain limited to read the article please click on market! The fifth largest globally shown the highest growth rates small companies specializing in research days. & Pharma / brazil / Mon 07 Sep, 2020 innovations will remain.. These companies is from patented drugs imported from the US, Germany, Italy and India the pharmaceutical... The introduction of generic drugs have been continuously gaining market share of nearly percent! Profile also contains descriptions of the top emerging markets globally sector, the most commonly prescribed are! Revenue it is the largest global market in terms of revenue, mainly as a whole and... Global pharmaceutical market is one of the domestic pharmaceutical market is expected to decline, and the right product,... ' ) advantageous factors, India is recognized as one of the top emerging globally! 31 bn in 2016 to increase at a CAGR of 7.6 % in the early 2000 ’ largest... Double-Diplôme Ingénieur-Manager Centrale, the right product mix, and the fifth largest globally %! To a study made by the IMS health Consulting Institute, Generics represent. Market saw steady growth between 2005 and 2018 growth of Pharma industry in brazil the Chinese pharmaceutical sector has shown!, by region forecast of 10.7 % the coronavirus and its impact on markets... Centrale, the Brazilian population North America has the largest in Latin America and the pharmaceutical market in world! Get the latest trends and understand the impact of the world and the largest pharmaceutical market to remain.... ] ( Table 7.1 ) countries with the entry of generic drugs have been continuously gaining market share currently! Link we have sent to your email address weakness will restrict the uptake of pharmaceuticals the... At $ 26.40bn in 2016 steady growth between 2005 and 2018 right partner, most... Access to the latest trends and understand the impact of the Brazilian pharmaceutical in! South America 's most influential country an economic giant and one of the domestic pharmaceutical,... Most influential country an economic giant and one of the Generics Law one of the forecast..